Aligos Therapeutics Inc (ALGS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | ALGS | AZN | AMGN | GILD | BMY |
| Company | Aligos Therapeutics Inc | Astrazeneca Plc | Amgen Inc | Gilead Sciences Inc | Bristol-Myers Squibb Company |
| Price Information | |||||
| Exchange | NASDAQ | NYSE | NASDAQ | NASDAQ | NYSE |
| Open | 6.94 | 187.67 | 350.76 | 139.76 | 57.79 |
| High | 7.38 | 188.72 | 358.00 | 140.42 | 59.39 |
| Low | 6.81 | 186.44 | 350.76 | 138.71 | 57.79 |
| Latest | 6.87 | 187.72 | 354.29 | 138.58 | 58.89 |
| Change | +0.08 | +1.94 | +5.86 | +0.47 | +1.50 |
| % Change | +1.18% | +1.04% | +1.68% | +0.34% | +2.61% |
| Volume | 19,470 | 881,164 | 793,577 | 2,003,397 | 5,068,784 |
| 20-Day Average Volume | 39,602 | 1,835,388 | 2,692,239 | 6,630,329 | 14,511,643 |
| Previous Close | 6.79 | 185.78 | 348.43 | 138.11 | 57.39 |
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical |
| Has Options | No | Yes | Yes | Yes | Yes |
| Technicals | |||||
| 20-Day Moving Average | 7.11 | 193.95 | 367.00 | 144.15 | 59.85 |
| 20-Day Raw Stochastic | 35.56% | 20.52% | 20.63% | 18.28% | 39.77% |
| 20-Day Relative Strength | 45.80 | 44.43 | 46.26 | 45.18 | 51.12 |
| Weighted Alpha | -41.96 | +28.35 | +19.68 | +27.34 | +9.87 |
| Today's Opinion | 100% Sell | 56% Buy | 56% Buy | 56% Buy | 72% Buy |
| Previous Opinion | 100% Sell | 40% Buy | 56% Buy | 56% Buy | 56% Buy |
| Last Month's Opinion | 72% Sell | 100% Buy | 100% Buy | 88% Buy | 100% Buy |
| Performance | |||||
| 5-Days | |||||
| %Chg | unch since 03/18/26 | -0.20% since 03/18/26 | +0.86% since 03/18/26 | -1.58% since 03/18/26 | -0.61% since 03/18/26 |
| Low | 6.61 on 03/24/26 | 182.39 on 03/24/26 | 344.95 on 03/20/26 | 136.44 on 03/23/26 | 56.45 on 03/24/26 |
| High | 7.55 on 03/20/26 | 189.79 on 03/19/26 | 357.99 on 03/25/26 | 142.09 on 03/19/26 | 59.64 on 03/19/26 |
| 1-Month | |||||
| %Chg | +0.14% since 02/25/26 | -8.63% since 02/25/26 | -7.76% since 02/25/26 | -5.48% since 02/25/26 | -3.74% since 02/25/26 |
| Low | 6.31 on 03/02/26 | 182.39 on 03/24/26 | 344.95 on 03/20/26 | 136.44 on 03/23/26 | 56.45 on 03/24/26 |
| High | 8.11 on 03/16/26 | 209.93 on 02/27/26 | 391.29 on 03/02/26 | 150.77 on 03/02/26 | 62.89 on 03/02/26 |
| 3-Month | |||||
| %Chg | -33.94% since 12/24/25 | +1.70% since 12/24/25 | +6.15% since 12/24/25 | +10.65% since 12/24/25 | +7.86% since 12/24/25 |
| Low | 6.23 on 02/17/26 | 178.08 on 01/21/26 | 318.21 on 01/05/26 | 116.88 on 01/05/26 | 52.06 on 01/05/26 |
| High | 10.50 on 12/26/25 | 212.71 on 02/18/26 | 391.29 on 03/02/26 | 157.29 on 02/11/26 | 62.89 on 03/02/26 |
| 6-Month | |||||
| %Chg | -25.75% since 09/25/25 | +27.87% since 09/25/25 | +30.73% since 09/25/25 | +25.29% since 09/25/25 | +35.94% since 09/25/25 |
| Low | 5.81 on 11/14/25 | 146.66 on 09/26/25 | 269.77 on 09/26/25 | 108.46 on 10/02/25 | 42.52 on 10/29/25 |
| High | 13.69 on 12/15/25 | 212.71 on 02/18/26 | 391.29 on 03/02/26 | 157.29 on 02/11/26 | 62.89 on 03/02/26 |
| Key Statistics | |||||
| Market Capitalization, $K | 42,015 | 288,127,680 | 187,827,456 | 171,425,184 | 116,873,240 |
| Shares Outstanding, K | 6,188 | 1,550,908 | 539,068 | 1,241,222 | 2,036,474 |
| Annual Sales | 2,190,000 | 58,739,000,000 | 36,751,000,000 | 29,443,000,000 | 48,194,000,000 |
| Annual Net Income | -24,190,000 | 10,225,000,000 | 7,711,000,000 | 8,510,000,000 | 7,054,000,000 |
| Last Quarter Sales | 170,000 | 15,503,000,000 | 9,866,000,000 | 7,925,000,000 | 12,502,000,000 |
| Last Quarter Net Income | -19,880,000 | 2,321,000,000 | 1,333,000,000 | 2,183,000,000 | 1,086,000,000 |
| 60-Month Beta | 2.67 | 0.32 | 0.45 | 0.37 | 0.26 |
| Per-Share Information | |||||
| Most Recent Earnings | -1.91 on 03/05/26 | 2.12 on 02/10/26 | 5.29 on 02/03/26 | 1.86 on 02/10/26 | 1.26 on 02/05/26 |
| Latest Earnings Date | 05/05/26 | 05/05/26 | 05/07/26 | 04/23/26 | 04/30/26 |
| Most Recent Dividend | N/A | 2.170 on 02/20/26 | 2.520 on 02/13/26 | 0.820 on 03/13/26 | 0.630 on 01/02/26 |
| Next Ex-Dividends Date | N/A | 02/20/26 | 05/15/26 | 03/13/26 | 04/02/26 |
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 20.09 | 16.01 | 16.85 | 9.27 |